Free press releases distribution network?

More news: Health/Surgery
Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Central and Eastern European Healthcare Markets Hold Strong Potential for Growth Despite the Economic Slowdown Says Frost & Sullivan - Despite the global economic decline, Central and Eastern European (CEE) countries such as Poland, the Czech Republic, Slovakia, Hungary, Bulgaria and Romania still represent an attractive healthcare market
Central and Eastern European Healthcare Markets Hold Strong Potential for Growth Despite the Economic Slowdown Says Frost & Sullivan

 

PRZOOM - /newswire/ - London, United Kingdom, 2009/11/10 - Despite the global economic decline, Central and Eastern European (CEE) countries such as Poland, the Czech Republic, Slovakia, Hungary, Bulgaria and Romania still represent an attractive healthcare market.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Both the pharmaceutical as well as medical devices segments have not developed to their full potential, with healthcare expenditures expected to rise further. The increasing importance of this market is attracting multinational corporations (MNCs) for developing proprietary or acquiring local production sites. Merger with or an acquisition of a local market participant is considered as the most efficient way to access the local market and to further expand into the CEE markets.

New analysis from Frost & Sullivan (pharma.frost.com), Overview of Pharmaceutical and Medical Devices Industry in Central and Eastern Europe, finds that the pharmaceutical and medical devices market will grow on average at 6.9 per cent and 7.4 per cent respectively from 2009 to 2012. Bulgaria and Romania will be the fastest-growing markets, while the Czech and Hungarian markets will experience below-average growth.

"On one hand, the Western European markets are saturated with marginal scope for growth," says Frost & Sullivan Research Analyst Vitaliy Lehkyy. "On the other hand, CEE countries still boast of an unmet demand for pharmaceuticals and medical devices, driven by the rising purchasing power of the population."

CEE pharmaceutical and medical devices markets are on average 1.5 to five times smaller in value terms per capita than the Western European ones. The improving economic position of countries in the region is resulting in a better quality of life, higher life expectancy and a consequent demand for efficient healthcare services by the ageing population.

However, the markets will be restrained by incoherent reforms of the healthcare system and volatile regulatory requirements imposed on market participants.

"For instance, compulsory fees for drug prescription in the Czech Republic and Hungary, a new pharmaceutical pricing scheme in Slovakia, and mandatory labelling of all medicaments in Cyrillic alphabet in Bulgaria, will adversely affect the market in the short-term," explains Lehkyy. "These measures imply an additional cost pressure either on consumers or drug-manufacturers and will have an adverse effect on the development of pharmaceutical markets in these countries."

Therefore, timely and effective response from government authorities will be crucial to the favourable development of the healthcare market in CEE.

If you are interested in more information about this study, then send an email to Katja Feick, Corporate Communications, at katja.feick[.]frost.com, with your full name, company name, title, telephone number, company email address, company website, city, state and country.

Overview of Pharmaceutical and Medical Devices Industry in Central and Eastern Europe is part of the Pharmaceuticals & Biotechnology Growth Partnership Services programme, which also includes research in the following markets: Global Active Pharmaceutical Ingredients Market Outlook, European Biomarker Analysis Market, and Emerging Therapeutic Segments in the European Biopharmaceutical Market. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 35 offices on six continents.

Overview of Pharmaceutical and Medical Devices Industry in Central and Eastern Europe / M416

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Central and Eastern European Healthcare Markets Hold Strong Potential for Growth Despite the Economic Slowdown Says Frost & Sullivan

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Frost & Sullivan |
Contact: Katja Feick 
+49 (0) 69 7703343 katja.feick[.]frost.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Frost & Sullivan / Company Profile


Read Health/Surgery Most Recent Related Press Releases:

Sustainable Alternatives to Polyvinylidene Chloride-coated Films Create Growth Opportunities & Transform the Food Packaging Markets in Western Europe
RIKEN Biofunctional Synthetic Chemistry Laboratory in Japan Has Developed A Way to Engineer Glycan Complexes Clusters of Sugar Chains
The Clinicians of Longs Peak Emergency Physicians Join US Acute Care Solutions
Frost & Sullivan Recognizes BroadReach for Improving the Health and Wellbeing of Underserved Populations
Silver Spring Emergency Physicians Join US Acute Care Solutions
Stress Light Therapy Launches Crowd-Funded Campaign on Indiegogo.com
Frost & Sullivan Names Optum 2016 North America Company of the Year for Population Health Management
R-Pharm Produces Biological Drugs in Yaroslavl with GE Healthcare's FlexFactory™ Manufacturing Platform
GE to Invest €150 Million in Biopharmaceutical Manufacturing Campus in Cork, Ireland, and Establish Advanced Manufacturing Training Centre At NIBRT
Ultimate Medical Group Announces A New Regenerative Medicine Division

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  BizJobs.com

Visit  JobsWare.com

Visit  K A C, Images and U, LLC







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today